Afamelanotide in protoporphyria and other skin diseases: a review

被引：1

作者：

Polanska, Adriana ^{[1
,3
]}

Wegner, Joanna ^{[2
]}

Nutbohm, Paula ^{[2
]}

Staubach, Petra ^{[2
]}

Zaba, Ryszard ^{[1
]}

Danczak-Pazdrowska, Aleksandra ^{[1
]}

Jenerowicz, Dorota ^{[1
]}

机构：

[1] Poznan Univ Med Sci, Dept Dermatol, Poznan, Poland

[2] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany

[3] Univ Med Sci, Dept Dermatol, 49 Przybyszewskiego St, PL-60355 Poznan, Poland

来源：

POSTEPY DERMATOLOGII I ALERGOLOGII | 2024年 / 41卷 / 02期

关键词：

afamelanotide; protoporphyria; erythropoietic porphyria; MELANOCYTE-STIMULATING HORMONE; ULTRAVIOLET-B PHOTOTHERAPY; ERYTHROPOIETIC PROTOPORPHYRIA; ALPHA-MELANOTROPIN; GENE VARIANTS; BETA-CAROTENE; ANALOG; PIGMENTATION; VITILIGO; EFFICACY;

D O I：

10.5114/ada.2024.138818

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Afamelanotide is a synthetic alpha melanocyte stimulating hormone presenting a higher activity than natural hormones. Its main properties are related to the enhanced production of eumelanin by agonistically binding to the melanocortin-1 receptor. Since 2016 afamelanotide has been especially applied to treat cases of erythropoietic porphyria (EPP), where painful photosensitivity has been observed since early childhood. The positive effect of af - amelanotide in EPP administered subcutaneously improved tolerance to artificial white light and increased pain -free time spent in direct sunlight. In this review we summarize the possible use of afamelanotide in dermatology, with special emphasis on EPP and encourage including afamelanotide as a treatment option in patient care.

引用

页码：149 / 154

页数：6

共 50 条

[11] Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria
Minder, Elisabeth I.
Schneider-Yin, Xiaoye
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 43 - 53
[12] Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide
Wensink, Debby
Wagenmakers, Margreet A. E. M.
Wilson, J. H. Paul
Langendonk, Janneke G.
JOURNAL OF DERMATOLOGY, 2023, 50 (04): : 445 - 452
[13] Cutaneous Effects of alpha-MSH Analogue Afamelanotide in erythropoietic Protoporphyria Treatment
Uche-Holub, E.
Siegesmund, M.
Kuerten, V
Bodden, G.
Strunk, T.
Poblete-Gutierrez, P.
Anstey, A., V
Neumann, N. J.
Frank, J.
Hanneken, S.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (11): : 863 - 863
[14] BETA CAROTENE THERAPY FOR ERYTHROPOIETIC PROTOPORPHYRIA AND OTHER PHOTOSENSITIVITY DISEASES
MATHEWSROTH, MM
PATHAK, MA
FITZPATRICK, TB
HARBER, LH
KASS, EH
ARCHIVES OF DERMATOLOGY, 1977, 113 (09) : 1229 - 1232
[15] Association of quality of life measures with afamelanotide treatment in patients with erythropoietic protoporphyria and x-linked protoporphyria: A retrospective cohort study
Ceresnie, Marissa S.
Mohney, Lindsey
Ko, Dayoung
Lim, Henry W.
Mohammad, Tasneem F.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (04) : 880 - 882
[16] Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria
Minder, Elisabeth I.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (12) : 1591 - 1602
[17] Vitamin D status in patients with erythropoietic protoporphyria taking the systemic photoprotective agent afamelanotide
Rhodes, Lesley E.
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 317 - 318
[18] Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria
Biolcati, G.
Marchesini, E.
Sorge, F.
Barbieri, L.
Schneider-Yin, X.
Minder, E. I.
BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (06) : 1601 - 1612
[19] The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study
Kluijver, Louisa G.
Shahraki, Mitra Nekouei
Wagenmakers, Margreet A. E. M.
Hanssen, Bettina E.
Kuerten, Viola
Schelonke, Kathrin
Homey, Bernhard
Langendonk, Janneke G.
BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (03) : 357 - 364
[20] BETA-CAROTENE THERAPY FOR ERYTHROPOIETIC PROTOPORPHYRIA AND OTHER PHOTOSENSITIVITY DISEASES
MATHEWSROTH, MM
BIOCHIMIE, 1986, 68 (06) : 875 - 884

← 1 2 3 4 5 →